Stocks paused after a tech-led swing: S&P 500 and Nasdaq cooled as mega‑cap earnings mixed, though futures ticked up overnight. The Dow lagged less, but volatility spiked around AI capex headlines, Nvidia’s record run and the Fed’s rate‑cut messaging. Yield and dollar moves, plus trade‑truce headlines, remain key catalysts.
A high-stakes meeting between Presidents Trump and Xi produced a tactical pause in their trade battle, including a one-year tariff truce. Markets and industries are parsing who gained leverage as details on rare earths and tariffs remain murky.
250M – Active users of Amazon’s AI assistant Rufus.
Nvidia’s surge has reshaped market narratives, vaulting it into the $5 trillion club and sparking new strategic bets. Investors and banks are repositioning around Nvidia-driven AI winners and follow-on funding moves.
Amazon’s quarter showed strength in cloud and retail, sending shares higher and prompting a heftier capex outlook. The company’s AI-driven cloud investment is now central to investor expectations for growth.
Alphabet posts first-ever $100B quarter
Alphabet’s record quarter, driven by Google Cloud and ad strength, underscores the resilience of Big Tech and supports a bullish case for continued AI-driven revenue growth.
More on entrepreneur.com
Apple posted a solid quarter but mixed regional results, with iPhone sales and services underpinning revenue. Management offered upbeat holiday guidance that calmed early investor worries about China weakness.
The Federal Reserve cut rates again, but policymakers signaled uncertainty on future moves, creating market ambiguity. Powell’s comments and internal Fed debate widened dispersion in rate-cut expectations.
WPP results called ‘unacceptable’ – turnaround pressure intensifies
WPP reported weak results and a management review that signals potential job cuts and strategic overhaul, leaving investors skittish about the ad giant’s recovery path.
More on digiday.com
The US government shutdown extended into a fifth week, threatening benefits and services while talks sputter in Washington. SNAP funding and other near-term deadlines are forcing state intervention and legal challenges.
President Trump’s call to resume nuclear testing marks a major policy shift, prompting Pentagon directives and global concern. The announcement has immediate diplomatic and defence implications.
U.S. and China agreed a one‑year pause on certain tariffs and China suspended select rare‑earth export curbs; the Fed cut rates again but signalled uncertainty on follow‑ups; the administration moved to resume nuclear testing and finalized rules narrowing PSLF eligibility.
Meta’s AI spending binge has jolted markets; the company is tapping debt markets to finance a massive capex plan. Investors are weighing the long-term payoff of aggressive AI investment against near-term profit pressure.
OpenAI’s IPO plans are back in the spotlight, with reports of a very large target valuation as costs mount. The potential float would be one of the biggest tech listings and reshape AI-capital markets.
“This is a fragile truce — it buys time, not trust.”
— Matt Pottinger (former deputy national security adviser)
Fiserv’s earnings shock and guidance reset triggered a dramatic share collapse, spotlighting execution and regional exposure risks. Wall Street is debating if the rout reflects deeper client or macro problems.
Regulatory action and safety concerns drove a large voluntary recall of blood-pressure drugs, prompting scrutiny of manufacturers. The FDA and firms are racing to trace batches and warn patients.
Hurricane Melissa inflicted catastrophic damage across Jamaica, triggering insurance and catastrophe‑bond mechanisms. Satellite imagery is being used to assess losses and activate recovery funding.
A planned $9 billion merger between AI-infrastructure firms unraveled after investor backlash, jolting both stocks. The deal’s collapse raises questions over valuations in the AI data‑center boom.
The obesity and diabetes drug market is heating into a bidding war as Novo and Eli Lilly push for assets that can extend growth. Big pharma jockeying is driving high-priced offers and legal threats.
Crypto and exchange firms posted strong top-line numbers as trading volumes recovered, suggesting a tentative revival in digital-asset activity. Investors are watching whether the momentum sticks amid macro shifts.
Ethereum developers have locked in a December 3 hard fork that sets key protocol upgrades in motion. The community is preparing node and client updates ahead of the network change.
BYD reported a sharp profit drop at home even as overseas sales surge, highlighting China demand softness and aggressive international expansion. The divergence underscores challenges for Chinese EV leaders.
Markets ended the session lower after megacap tech softness, though futures showed tentative gains as investors parsed earnings and Fed signals. Volatility remains elevated with AI and macro data driving flows.